Showing results (1851-1860 of 2,563) with videos related to

Sort By:
Pageof 257
Inflammopharmacology|June 24, 2026
Syagrus coronata fixed oil attenuates inflammation, oxidative stress and pulmonary alterations in L-arginine-induced pancreatitisBruna de Sousa Gomes, Beatriz Meyruze Barros da Fonsêca, Laís Ruanita Leopoldina Galvão, et al.
Inflammopharmacology|June 24, 2026
Therapeutic evaluation of artocarpin-enriched extract from Artocarpus heterophyllus heartwood in multiple sclerosis rat modelHumaira Majeed, Rizwan Rashid Bazmi, Malik SaadUllah, et al.
Inflammopharmacology|June 24, 2026
Targeting oxidative stress, senescence, and neurodegeneration: anti-aging perspectives of Urtica dioica and Centella asiaticaPratiksha Dobriyal, Vaishnavi Singh, Falguni Goel, et al.
Inflammopharmacology|June 27, 2026
A new paradigm in Parkinson's disease: kidney-origin α-synuclein pathology driven by PKC signaling and aurothioglucoseKanika Vashisht, Varun Sharma, Mahendra Singh Ashawat, et al.
Inflammopharmacology|June 4, 2026
Anti-acne cinnamic acid bigel: a hybrid topical system for concurrent modulation of inflammation and microbial loadJitendra W Gajbe, Ashwini R Madgulkar, Minakshi B Shinde, et al.
Inflammopharmacology|May 25, 2026
Kaempferol-loaded solid lipid nanoparticles attenuate cartilage degradation and inflammation by modulating the expression of pro and inflammatory cytokines, MMP-13 and oxidative stress markers in adjuvant induced arthritic ratsAnam Niamat, Aftab Ahmad, Nayla Munawar, et al.
Inflammopharmacology|May 20, 2026
Inhibiting pyruvate carboxylase as a potential therapeutic strategy for alleviating rheumatoid arthritisSzu-Wei Huang, Hui-Chun Yu, Hsien-Bin Huang, et al.
Inflammopharmacology|April 27, 2026
Chitosan-curcumin nanoparticles: a potential nano-therapeutic for cognitive restoration in a streptozotocin-induced rat model of Alzheimer's diseaseMohadeseh Shiravi Khozani, Mohammadreza Palizvan, Ghasem Mosayebi, et al.
Inflammopharmacology|May 15, 2026
Importance of the inflammasome in gut-brain axis: from pathological driver to therapeutic targetSubham Sarkar, Souvik Roy, Lopamudra Choudhury
Inflammopharmacology|July 17, 2026
Nanomedicine targeting neuroinflammatory pathways in Alzheimer's disease: a new frontier in inflammopharmacologySumit Kaushik, Jamal E Fatima, Amatul Raheem, et al.
Pageof 257